Matthew Starr
@Tenor Capital Management Co., L.p.
Latest period2024 - Q3ReportedManaged Assets$7.131TTotal holdings292
Assets growth rate12.01%Assets growth rate (2-Q avg)6.8%Continuous growth in asset value4 quarters
Portfolio positions
This chart displays the top 10 holdings in Tenor Capital Management Co., L.p.'s 2024 - Q3 portfolio, based on their 13F SEC filing, out of a total of 292 positions.
Assets under management
The assets under management (AUM) of Tenor Capital Management Co., L.p. over the past 10 years (40 quarters) show continuous growth in total asset value over the last 4 quarters. As of the latest 13F SEC filing for 2024 - Q3, they manage 7.131T in assets, with a quarterly growth rate of 12.01% and a 2-quarter average growth rate of 6.8%. The portfolio is managed by Matthew Starr, and others.
Portfolio holdings
Investment | Portfolio % | Reported Value | Recent Activity |
---|---|---|---|
6323⤦Natera Inc
| 0% | $126.77B 44.447M shares@ $2852.18 avg price | Exited |
5312⤦Liberty Media Corp
| 0% | $123.675B 128.532M shares@ $962.22 avg price | Exited |
0174⤦Ati Inc
| 0% | $114.01B 31.8M shares@ $3585.21 avg price | Exited |
4721⤦Jazz Investments I Ltd
| 0% | $87.784B 87.773M shares@ $1000.13 avg price | Exited |
7801⤦Royal Caribbean Group
| 0% | $81.33B 25M shares@ $3253.2 avg price | Exited |
2997⤦Everbridge Inc
| 0% | $57.06B 57.746M shares@ $988.13 avg price | Exited |
0906⤦Biomarin Pharmaceutical Inc
| 0% | $23.648B 23.693M shares@ $998.11 avg price | Exited |
4063⤦Halozyme Therapeutics Inc
| 0% | $17.194B 18M shares@ $955.24 avg price | Exited |
0237⤦American Airlines Group Inc
| 0% | $12.811B 12M shares@ $1067.63 avg price | Exited |
4622⤦Ionis Pharmaceuticals Inc
| 0% | $11.049B 10M shares@ $1104.89 avg price | Exited |